Body mass index trends and its impact of under and overweight on outcome among PLHIV on antiretroviral treatment in rural Tanzania: A prospective cohort study.

<h4>Introduction</h4>Increased body weight is an important risk factor for cardiovascular disease and is increasingly reported as a health problem in people living with HIV (PLHIV). There is limited data from rural sub-Saharan Africa, where malnutrition usually presents with both over- a...

Full description

Bibliographic Details
Main Authors: Aneth Vedastus Kalinjuma, Hannah Hussey, Getrud Joseph Mollel, Emilio Letang, Manuel Battegay, Tracy R Glass, Daniel Paris, Fiona Vanobberghen, Maja Weisser, KIULARCO study group
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0290445&type=printable
_version_ 1797690891403526144
author Aneth Vedastus Kalinjuma
Hannah Hussey
Getrud Joseph Mollel
Emilio Letang
Manuel Battegay
Tracy R Glass
Daniel Paris
Fiona Vanobberghen
Maja Weisser
KIULARCO study group
author_facet Aneth Vedastus Kalinjuma
Hannah Hussey
Getrud Joseph Mollel
Emilio Letang
Manuel Battegay
Tracy R Glass
Daniel Paris
Fiona Vanobberghen
Maja Weisser
KIULARCO study group
author_sort Aneth Vedastus Kalinjuma
collection DOAJ
description <h4>Introduction</h4>Increased body weight is an important risk factor for cardiovascular disease and is increasingly reported as a health problem in people living with HIV (PLHIV). There is limited data from rural sub-Saharan Africa, where malnutrition usually presents with both over- and undernutrition. We aimed to determine the prevalence and risk factors of underweight and overweight/obesity in PLHIV enrolled in a cohort in rural Tanzania before the introduction of integrase inhibitors.<h4>Methods</h4>This nested study of the prospective Kilombero and Ulanga Antiretroviral Cohort included adults aged ≥19 years initiated on antiretroviral therapy between 01/2013 and 12/2018 with follow-up through 06/2019. Body Mass Index (BMI) was classified as underweight (<18.5 kg/m2), normal (18.5-24.9 kg/m2), or overweight/obese (≥25.0 kg/m2). Stratified piecewise linear mixed models were used to assess the association between baseline characteristics and follow-up BMI. Cox proportional hazard models were used to assess the association between time-updated BMI and death/loss to follow-up (LTFU).<h4>Results</h4>Among 2,129 patients, 22,027 BMI measurements (median 9 measurements: interquartile range 5-15) were analysed. At baseline, 398 (19%) patients were underweight and 356 (17%) were overweight/obese. The majority of patients were female (n = 1249; 59%), and aged 35-44 years (779; 37%). During the first 9 months, for every three additional months on antiretroviral therapy, BMI increased by 2% (95% confidence interval 1-2%, p<0.0001) among patients underweight at baseline and by 0.7% (0.5-0.6%, p<0.0001) among participants with normal BMI. Over a median of 20 months of follow-up, 107 (5%) patients died and 592 (28%) were LTFU. Being underweight was associated with >2 times the hazard of death/LTFU compared to participants with normal BMI.<h4>Conclusion</h4>We found a double burden of malnutrition, with underweight being an independent predictor of mortality. Monitoring and measures to address both states of malnutrition among PLHIV should be integrated into routine HIV care.
first_indexed 2024-03-12T02:05:38Z
format Article
id doaj.art-d82ad3b27ef54d8b800e2394b3800840
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-03-12T02:05:38Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d82ad3b27ef54d8b800e2394b38008402023-09-07T05:31:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01188e029044510.1371/journal.pone.0290445Body mass index trends and its impact of under and overweight on outcome among PLHIV on antiretroviral treatment in rural Tanzania: A prospective cohort study.Aneth Vedastus KalinjumaHannah HusseyGetrud Joseph MollelEmilio LetangManuel BattegayTracy R GlassDaniel ParisFiona VanobberghenMaja WeisserKIULARCO study group<h4>Introduction</h4>Increased body weight is an important risk factor for cardiovascular disease and is increasingly reported as a health problem in people living with HIV (PLHIV). There is limited data from rural sub-Saharan Africa, where malnutrition usually presents with both over- and undernutrition. We aimed to determine the prevalence and risk factors of underweight and overweight/obesity in PLHIV enrolled in a cohort in rural Tanzania before the introduction of integrase inhibitors.<h4>Methods</h4>This nested study of the prospective Kilombero and Ulanga Antiretroviral Cohort included adults aged ≥19 years initiated on antiretroviral therapy between 01/2013 and 12/2018 with follow-up through 06/2019. Body Mass Index (BMI) was classified as underweight (<18.5 kg/m2), normal (18.5-24.9 kg/m2), or overweight/obese (≥25.0 kg/m2). Stratified piecewise linear mixed models were used to assess the association between baseline characteristics and follow-up BMI. Cox proportional hazard models were used to assess the association between time-updated BMI and death/loss to follow-up (LTFU).<h4>Results</h4>Among 2,129 patients, 22,027 BMI measurements (median 9 measurements: interquartile range 5-15) were analysed. At baseline, 398 (19%) patients were underweight and 356 (17%) were overweight/obese. The majority of patients were female (n = 1249; 59%), and aged 35-44 years (779; 37%). During the first 9 months, for every three additional months on antiretroviral therapy, BMI increased by 2% (95% confidence interval 1-2%, p<0.0001) among patients underweight at baseline and by 0.7% (0.5-0.6%, p<0.0001) among participants with normal BMI. Over a median of 20 months of follow-up, 107 (5%) patients died and 592 (28%) were LTFU. Being underweight was associated with >2 times the hazard of death/LTFU compared to participants with normal BMI.<h4>Conclusion</h4>We found a double burden of malnutrition, with underweight being an independent predictor of mortality. Monitoring and measures to address both states of malnutrition among PLHIV should be integrated into routine HIV care.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0290445&type=printable
spellingShingle Aneth Vedastus Kalinjuma
Hannah Hussey
Getrud Joseph Mollel
Emilio Letang
Manuel Battegay
Tracy R Glass
Daniel Paris
Fiona Vanobberghen
Maja Weisser
KIULARCO study group
Body mass index trends and its impact of under and overweight on outcome among PLHIV on antiretroviral treatment in rural Tanzania: A prospective cohort study.
PLoS ONE
title Body mass index trends and its impact of under and overweight on outcome among PLHIV on antiretroviral treatment in rural Tanzania: A prospective cohort study.
title_full Body mass index trends and its impact of under and overweight on outcome among PLHIV on antiretroviral treatment in rural Tanzania: A prospective cohort study.
title_fullStr Body mass index trends and its impact of under and overweight on outcome among PLHIV on antiretroviral treatment in rural Tanzania: A prospective cohort study.
title_full_unstemmed Body mass index trends and its impact of under and overweight on outcome among PLHIV on antiretroviral treatment in rural Tanzania: A prospective cohort study.
title_short Body mass index trends and its impact of under and overweight on outcome among PLHIV on antiretroviral treatment in rural Tanzania: A prospective cohort study.
title_sort body mass index trends and its impact of under and overweight on outcome among plhiv on antiretroviral treatment in rural tanzania a prospective cohort study
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0290445&type=printable
work_keys_str_mv AT anethvedastuskalinjuma bodymassindextrendsanditsimpactofunderandoverweightonoutcomeamongplhivonantiretroviraltreatmentinruraltanzaniaaprospectivecohortstudy
AT hannahhussey bodymassindextrendsanditsimpactofunderandoverweightonoutcomeamongplhivonantiretroviraltreatmentinruraltanzaniaaprospectivecohortstudy
AT getrudjosephmollel bodymassindextrendsanditsimpactofunderandoverweightonoutcomeamongplhivonantiretroviraltreatmentinruraltanzaniaaprospectivecohortstudy
AT emilioletang bodymassindextrendsanditsimpactofunderandoverweightonoutcomeamongplhivonantiretroviraltreatmentinruraltanzaniaaprospectivecohortstudy
AT manuelbattegay bodymassindextrendsanditsimpactofunderandoverweightonoutcomeamongplhivonantiretroviraltreatmentinruraltanzaniaaprospectivecohortstudy
AT tracyrglass bodymassindextrendsanditsimpactofunderandoverweightonoutcomeamongplhivonantiretroviraltreatmentinruraltanzaniaaprospectivecohortstudy
AT danielparis bodymassindextrendsanditsimpactofunderandoverweightonoutcomeamongplhivonantiretroviraltreatmentinruraltanzaniaaprospectivecohortstudy
AT fionavanobberghen bodymassindextrendsanditsimpactofunderandoverweightonoutcomeamongplhivonantiretroviraltreatmentinruraltanzaniaaprospectivecohortstudy
AT majaweisser bodymassindextrendsanditsimpactofunderandoverweightonoutcomeamongplhivonantiretroviraltreatmentinruraltanzaniaaprospectivecohortstudy
AT kiularcostudygroup bodymassindextrendsanditsimpactofunderandoverweightonoutcomeamongplhivonantiretroviraltreatmentinruraltanzaniaaprospectivecohortstudy